Gulliver Biomed Research and application of Nanobodies® in immunomodulation

Category: Cell Therapy and Regenerative Medicine

Booth No: M807

Characteristic

Gulliver Biomed (https://gulliverbiomed.com) builds further on the expertise acquired in the field of immunomodulation. We aim to foster nanobody research in general and bring these powerful tools to the scientific community and private industry at large. It is active in the biomedical sector and develops its own portfolio of so-called llama single domain antibodies. These are very small antibodies. They are 10 times smaller compared to regular antibodies and can be used as a research tool in biomedical laboratories, as a diagnostic or as a therapeutic. In addition, Gulliver Biomed develops (custom' llama single domain antibodies for clients, worldwide, both for academia as well as for private enterprises. This activity requires further development.